Back to DE Deerfield Management Company, L.P.

NBIX

Showing 7 of 22 quarters

Position history for DEDeerfield Management Company, L.P.'s holdings in Neurocrine Biosciences, Inc.

No. Deerfield Management exited its NBIX (Neurocrine Biosciences) position in Q2 2026. Its Q1 2026 13F listed 610,000 shares worth $80.4M. Deerfield Management first reported NBIX in Q1 2021 and held it in 21 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$117.7M

Total Shares Change

-862,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$168.54
0
2026-Q1
Decreased
610,000
-48.5%
$80.4M0.9%$131.74
0
2025-Q4
Unchanged
1.2M
0.0%
$168M2.1%$141.83
0
2025-Q3
Increased
1.2M
+1.4%
$166.3M2.5%$140.38
53
2025-Q2
Decreased
1.2M
-21.6%
$146.8M2.7%$125.69
0
2025-Q1
Increased
1.5M
+72.7%
$164.7M3.3%$110.60
84
2024-Q4
Decreased
862,000
-34.5%
$117.7M2.2%$136.50
0

Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.

Optional analytics helps us improve. How it’s used